Brain

Head:China makes collaborative efforts in healing people with mental disorders with AI

BEIJING, Nov. 20, 2024 /PRNewswire/ -- After a long day at work, Ni Beiyue sits in front of his computer at home,…

1 year ago

Embr Labs Named to Fast Company’s Fourth Annual List of The Next Big Things in Tech

List Recognizes Groundbreaking Advancements Redefining the Way We Work and Live BOSTON, Nov. 19, 2024 /PRNewswire/ -- Embr Labs, the…

1 year ago

Alara Human Tech Launches Revolutionary Halo™ EMF Protection For iPhone Models

Specifically engineered for iPhone 14 through 16, the Halo™ incorporates Alara's patented Array® technology to help protect users from harmful…

1 year ago

Anatomage Releases The World’s First Complete Digitized Monkey

SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Anatomage Inc., a pioneer in healthcare technology, announces the release of the world's…

1 year ago

Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives

NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company…

1 year ago

CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)

HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company…

1 year ago

NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders

ZÜRICH, SWITZERLAND / ACCESSWIRE / November 18, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

1 year ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant…

1 year ago